282 related articles for article (PubMed ID: 28957872)
21. [Value of delta model for end-stage liver disease in evaluating the prognosis of liver failure patients with hepatitis B virus].
Guo JC; Li CQ; Xun YH; Wang YF; Yu XL; Shi WZ; Shi JP; Lou CQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):48-50. PubMed ID: 22919754
[TBL] [Abstract][Full Text] [Related]
22. Proposal for a New Predictive Model of Short-Term Mortality After Living Donor Liver Transplantation due to Acute Liver Failure.
Chung HS; Lee YJ; Jo YS
Ann Transplant; 2017 Feb; 22():101-107. PubMed ID: 28220036
[TBL] [Abstract][Full Text] [Related]
23. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
24. Model for end-stage liver disease can predict very early outcome after liver transplantation.
Briceño J; Sánchez-Hidalgo JM; Naranjo A; Ciria R; Pozo JC; Luque A; de la Mata M; Rufián S; López-Cillero P
Transplant Proc; 2008 Nov; 40(9):2952-4. PubMed ID: 19010157
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
26. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
27. Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
Wronka KM; Grąt M; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Grąt K; Patkowski W; Krawczyk M
Ann Transplant; 2017 Apr; 22():251-256. PubMed ID: 28439063
[TBL] [Abstract][Full Text] [Related]
28. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
29. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
[TBL] [Abstract][Full Text] [Related]
30. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
31. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
32. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
[TBL] [Abstract][Full Text] [Related]
33. [Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures].
Wen L; He S; Zhang H; Luo X
Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):514-8. PubMed ID: 25203803
[TBL] [Abstract][Full Text] [Related]
34. Impact of the MELD allocation after its implementation in liver transplantation.
Benckert C; Quante M; Thelen A; Bartels M; Laudi S; Berg T; Kaisers U; Jonas S
Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of MELD-Na versus MELDNa in the prediction of short-term prognosis for acute-on-chronic hepatitis B liver failure].
He WP; Hu JH; Tong JJ; Liu FF; Wang HF
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1173-7. PubMed ID: 21756769
[TBL] [Abstract][Full Text] [Related]
37. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
[TBL] [Abstract][Full Text] [Related]
38. Potential predictive value of the MELD score for short-term mortality after liver transplantation.
Santori G; Andorno E; Antonucci A; Morelli N; Bottino G; Mondello R; Valente R; Panaro F; Ravazzoni F; Di Domenico S; Savelli A; Valente U
Transplant Proc; 2004 Apr; 36(3):533-4. PubMed ID: 15110583
[TBL] [Abstract][Full Text] [Related]
39. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
40. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
